Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real‐life experience. (4th October 2016)
- Record Type:
- Journal Article
- Title:
- Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real‐life experience. (4th October 2016)
- Main Title:
- Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real‐life experience
- Authors:
- Branger, Nicolas
Maubon, Thomas
Traumann, Miriam
Thomassin‐Piana, Jeanne
Brandone, Nicolas
Taix, Sébastien
Touzlian, Julien
Brunelle, Serge
Pignot, Geraldine
Salem, Naji
Gravis, Gwenaelle
Walz, Jochen - Abstract:
- Abstract : Objectives: To evaluate the histopathological results after radical prostatectomy (RP) in patients that had normal preoperative multiparametric magnetic resonance imaging (mpMRI), in order to determine whether they had significant or insignificant disease. Moreover, we evaluated the influence of the expertise of the radiologist on the results. Patients and Methods: We retrospectively included patients who underwent RP in our centre and who had a preoperative negative mpMRI. The MRIs were considered negative when no suspicious lesion was seen or when the Prostate Imaging Reporting and Data System version 1 score was <7. We used Pathological tumour‐node‐metastasis staging and Gleason score on pathology reports, and whole‐mount sections to calculate tumour volume. Results: We identified 101 patients from 2009 to 2015. Final pathology showed that 16.9% had extraprostatic extension, 13.8% had primary Gleason pattern 4 (4 + 3 and above), 47.5% had secondary Gleason pattern 4 or 5, and 55.9% and 20.6% had a main tumour volume of ≥0.5 and ≥2 mL, respectively. When limiting the analysis to expert reading only, the numbers improved: only one patient (3.4%) had extraprostatic extension ( P < 0.05), one patient (3.4%) had primary Gleason pattern 4 ( P = 0.05), and 64.7% and 5.9% had a main tumour volume of ≥0.5 and ≥2 mL, respectively ( P = 0.01). Conclusion: A negative MRI does not guarantee the absence of significant prostate cancer.
- Is Part Of:
- BJU international. Volume 119:Number 3(2017)
- Journal:
- BJU international
- Issue:
- Volume 119:Number 3(2017)
- Issue Display:
- Volume 119, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 119
- Issue:
- 3
- Issue Sort Value:
- 2017-0119-0003-0000
- Page Start:
- 449
- Page End:
- 455
- Publication Date:
- 2016-10-04
- Subjects:
- prostate cancer -- MRI -- multiparametric -- significant -- experience -- cancer volume
Genitourinary organs -- Diseases -- Periodicals
Genitourinary organs -- Surgery -- Periodicals
Urology -- Periodicals
616.6 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-410X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bju.13657 ↗
- Languages:
- English
- ISSNs:
- 1464-4096
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2105.758000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 309.xml